Stock EVE EVOLVA HOLDING SA
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Evolva Holding SA

Equities

EVE

CH1262055788

Market Closed - Swiss Exchange
Other stock markets
 11:31:51 2024-07-05 am EDT 		5-day change 1st Jan Change
0.91 CHF -1.09% Intraday chart for Evolva Holding SA 0.00% +26.39%
Apr. 15 Evolva Shareholders Pass Resolutions to Revoke Liquidation, Delisting MT
Mar. 26 Evolva Secures Temporary Exemption from Listing Rules Amid Liquidation MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Evolva Secures Temporary Exemption from Listing Rules Amid Liquidation
MT
Evolva Closes CHF20 Million Unit Sale to Lallemand's Danstar Ferment
MT
Danstar Ferment AG completed the acquisition of Evolva AG form Evolva Holding SA.
CI
Evolva Shareholders OK Unit Sale, Proposed Liquidation
MT
Evolva to Seek Shareholder Nod for Unit Sale, Proposed Liquidation
MT
Evolva Strikes CHF20 Million Deal to Sell Business to Lallemand's Danstar Ferment
MT
Danstar Ferment AG enters into an agreement to acquire Evolva AG form Evolva Holding SA for CHF 30 million.
CI
Evolva, Breko Sign Distribution Deal for Dietary Supplement Ingredient
MT
Evolva and Breko GmbH Broaden Partnership by Signing Agreement for the Exclusive Distribution of Veri-teTM Resveratrol in Germany, Austria, Thailand and Vietnam
CI
Evolva Signs Distribution Deal with Chemical Group Lehvoss
MT
Evolva and LEHVOSS Sign Agreement for Distribution of Veri-teTM Resveratrol in over A Dozen European Countries
CI
Evolva, Nice & Green Agree to Term Amendments for CHF5 Million Facility
MT
Evolva Wins Thai Regulatory Nod for Nature-based Ingredient Veri-teTM Resveratrol
MT
Evolva Receives Approval for Veri-Te Resveratrol in Thailand
CI
Evolva Posts Larger H1 Loss; Revenue Slides Down
MT
Evolva Holding SA Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Evolva Gets Approval for Veri-te Resveratrol Use in Taiwan
MT
Evolva Receives FDA Approval for Veri-teTM Resveratrol in Taiwan
CI
SIX Group Makes Index Adjustments Following Review
MT
Evolva Withdraws FY23 Guidance Amid Strategic Financing Review
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EVE Stock
  4. News Evolva Holding SA
  5. Highlights